Home|DSIJArticleDetail

Upper Circuit: This micro-cap pharma stock reported stellar Q3FY23 results!
Upper Circuit: This micro-cap pharma stock reported stellar Q3FY23 results!

Upper Circuit: This micro-cap pharma stock reported stellar Q3FY23 results!

In an aim to expand their product portfolio, the company is focusing on developing multiple manufacturing sites

Bhavya Rathod Article rating: 3.7

They initiated contract manufacturing from three new locations this quarter and with this, they are currently manufacturing at nine locations across India

DSIJ MINDSHARE

Mkt Commentary2-Jun, 2023

Mindshare3-Jun, 2023

Multibaggers3-Jun, 2023

Mindshare3-Jun, 2023

Mindshare3-Jun, 2023

Knowledge

General3-Jun, 2023

General2-Jun, 2023

Fundamental28-May, 2023

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Investment in securities market are subject to market risks.Read all the related documents carefully before investing.
Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Disclaimer | Disclosure | Terms & Condition | Privacy Statement | WhiteList